CEREBRAL VASOREACTIVITY ASSESSED WITH TRANSCRANIAL DOPPLER AND REGIONAL CEREBRAL BLOOD-FLOW MEASUREMENTS - DOSE, SERUM CONCENTRATION, AND TIME-COURSE OF THE RESPONSE TO ACETAZOLAMIDE
A. Dahl et al., CEREBRAL VASOREACTIVITY ASSESSED WITH TRANSCRANIAL DOPPLER AND REGIONAL CEREBRAL BLOOD-FLOW MEASUREMENTS - DOSE, SERUM CONCENTRATION, AND TIME-COURSE OF THE RESPONSE TO ACETAZOLAMIDE, Stroke, 26(12), 1995, pp. 2302-2306
Background and Purpose To improve the assessment of cerebral vasoreact
ivity using acetazolamide (ACZ), we studied the time course of the res
ponse and the relationship between dose, response, and serum concentra
tion. Methods Blood flow velocities were measured with the use of tran
scranial Doppler ultrasonography in one of the middle cerebral arterie
s of 48 healthy subjects after the intravenous administration of 1 to
1.6 g ACZ. In 34 subjects (group 1), velocities were measured every se
cond minute to detect the maximum middle cerebral artery velocity incr
ease. We also measured regional cerebral blood Row using single-photon
emission computed tomography in 27 of the subjects in group 1 before
and approximately 15 to 20 minutes after the ACZ injection. The serum
concentration of ACZ was measured in 15 subjects. In the remaining 14
subjects (group 2), middle cerebral artery velocity measurements were
made 10, 25, 30, and 45 minutes after ACZ administration to obtain inf
ormation regarding the late time course of the response. Results In gr
oup 1 the plateau phase of the velocity response was reached 8 to 15 m
inutes after ACZ administration. A large range of velocity increase wa
s observed, and a significant correlation was found between the maximu
m velocity increase and the dose and serum concentration of ACZ. In gr
oup 2 subjects, maximum velocities were maintained 30 minutes after th
e injection, but after 45 minutes velocities had decreased to 68% of t
heir highest level. No significant relationship was found between dose
or serum concentration of ACZ and the regional cerebral blood flow in
crease. The velocity increase after ACZ was similar in both older and
younger subjects. Conclusions This study shows that cerebral vasoreact
ivity is best assessed 10 to 30 minutes after ACZ administration and t
hat the dose should probably exceed 15 mg/kg if a maximum vasodilatory
response in the cerebral circulation is to be obtained.